Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Monthly information on share capital and company voting rights
By: GlobeNewswire - 04 Apr 2024Back to overview list

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, April 04, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

DateTotal number of shares
in the capital
Total number of voting rights
03/31/202471,953,53577,889,229

For further information on Cellectis, please contact:???? 

Media contact:?????? 

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO,?+33 (0)7 76 77 46 93, media@cellectis.com

Investor Relations contacts:?????? 

Arthur Stril, Chief Business Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617?430 7577? 

 

Attachment


Related companies:Cellectis Inc.
Copyright 2024 GlobeNewswire Back to overview list
to the top ↑